
January 2023 guidance from FDA on dosages in oncology provides further context on expectations with Project Optimus.
Director, Clinical Pharmacology and Translational Medicine, Certara

January 2023 guidance from FDA on dosages in oncology provides further context on expectations with Project Optimus.

Published: April 24th 2023 | Updated: